SMO and skin basal cell carcinoma: Significant up-modulation of PTCH2 and SMO transcripts confirmed the activation of Hh signalling in BCC-associated CAFs and suggested this anomaly as a possible priming mechanism for Hh signalling activation in absence of genetic aberration.